BERESIS; Richard Thomas
Patent Applications and Registrations
Patent applications and USPTO patent grants for BERESIS; Richard Thomas.The latest application filed is for "toll-like receptor antagonist compounds and methods of use".
Company Profile
11.17.30
- BERESIS; Richard Thomas - San Francisco CA
- Beresis; Richard Thomas - Shanghai CN
- Beresis; Richard Thomas. - Shanghai CN
- Beresis; Richard Thomas - Matawan NJ
Patent Activity
| Patent | Date |
|---|---|
| Toll-like Receptor Antagonist Compounds And Methods Of Use App 20220298162 - CANDIA; Albert Frederick ; et al. | 2022-09-22 |
| Toll-like receptor antagonist compounds and methods of use Grant 11,370,794 - Candia, III , et al. June 28, 2 | 2022-06-28 |
| 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof Grant 11,344,563 - Martinez Botella , et al. May 31, 2 | 2022-05-31 |
| 19-nor C3, 3-disubstituted C21-n-pyrazolyl Steroids And Methods Of Use Thereof App 20220110950 - Martinez Botella; Gabriel ; et al. | 2022-04-14 |
| 19-NOR neuroactive steroids and methods of use thereof Grant 11,261,211 - Martinez Botella , et al. March 1, 2 | 2022-03-01 |
| 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof Grant 11,241,446 - Martinez Botella , et al. February 8, 2 | 2022-02-08 |
| 19-nor Neuroactive Steroids And Methods Of Use Thereof App 20210139531 - Botella; Gabriel Martinez ; et al. | 2021-05-13 |
| Neuroactive Steroids, Compositions, And Uses Thereof App 20210061849 - Botella; Gabriel Martinez ; et al. | 2021-03-04 |
| Neuroactive Steriods, Compositions, And Uses Thereof App 20210061850 - Martinez Botella; Gabriel ; et al. | 2021-03-04 |
| Compositions And Methods For Treating Cns Disorders App 20210017218 - Martinez Botella; Gabriel ; et al. | 2021-01-21 |
| 19-nor neuroactive steroids and methods of use thereof Grant 10,822,370 - Botella , et al. November 3, 2 | 2020-11-03 |
| Compositions and methods for treating CNS disorders Grant 10,774,108 - Martinez Botella , et al. September 15, 2 | 2020-09-15 |
| Neuroactive Steroids, Compositions, And Uses Thereof App 20200165291 - Martinez Botella; Gabriel ; et al. | 2020-05-28 |
| 19-nor C3, 3-disubstituted C21-n-pyrazolyl Steroids And Methods Of Use Thereof App 20200155576 - Martinez Botella; Gabriel ; et al. | 2020-05-21 |
| 19-nor Neuroactive Steroids And Methods Of Use Thereof App 20200048300 - Martinez Botella; Gabriel ; et al. | 2020-02-13 |
| 19-nor C3, 3-disubstituted C21-c-bound Heteroaryl Steroids And Methods Of Use Thereof App 20200016178 - Martinez Botella; Gabriel ; et al. | 2020-01-16 |
| Toll-like Receptor Antagonist Compounds And Methods Of Use App 20190345161 - CANDIA, III; Albert Frederick ; et al. | 2019-11-14 |
| 19-nor neuroactive steroids and methods of use thereof Grant 10,377,790 - Martinez Botella , et al. A | 2019-08-13 |
| 19-nor Neuroactive Steroids And Methods Of Use Thereof App 20190211054 - Martinez Botella; Gabriel ; et al. | 2019-07-11 |
| 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof Grant 10,342,810 - Martinez Botella , et al. July 9, 2 | 2019-07-09 |
| 19-nor Neuroactive Steroids And Methods Of Use Thereof App 20190112331 - Botella; Gabriel Martinez ; et al. | 2019-04-18 |
| 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof Grant 10,172,871 - Martinez Botella , et al. J | 2019-01-08 |
| 19-nor C3, 3-disubstituted C21-n-pyrazolyl Steroids And Methods Of Use Thereof App 20180311262 - Martinez Botella; Gabriel ; et al. | 2018-11-01 |
| 19-nor neuroactive steroids and methods of use thereof Grant 10,023,606 - Martinez Botella , et al. July 17, 2 | 2018-07-17 |
| Neuroactive Steroids, Compositions, And Uses Thereof App 20180179247 - Botella; Gabriel Martinez ; et al. | 2018-06-28 |
| 19-nor Neuroactive Steroids And Methods Of Use Thereof App 20180051052 - Martinez Botella; Gabriel ; et al. | 2018-02-22 |
| RORgammaT inhibitors Grant 9,884,043 - Karstens , et al. February 6, 2 | 2018-02-06 |
| RORgammaT INHIBITORS App 20170340610 - Karstens; Willem Frederik Johan ; et al. | 2017-11-30 |
| Compositions And Methods For Treating Cns Disorders App 20170342102 - Martinez Botella; Gabriel ; et al. | 2017-11-30 |
| 19-nor C3, 3-disubstituted C21-n-pyrazolyl Steroids And Methods Of Use Thereof App 20170246191 - Martinez Botella; Gabriel ; et al. | 2017-08-31 |
| 19-nor Neuroactive Steroids And Methods Of Use Thereof App 20170233432 - Martinez Botella; Gabriel ; et al. | 2017-08-17 |
| 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof Grant 9,725,481 - Martinez Botella , et al. August 8, 2 | 2017-08-08 |
| RORgammaT inhibitors Grant 9,603,838 - Karstens , et al. March 28, 2 | 2017-03-28 |
| 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof Grant 9,512,165 - Martinez Botella , et al. December 6, 2 | 2016-12-06 |
| 19-NOR neuroactive steroids and methods of use thereof Grant 9,365,611 - Martinez Botella , et al. June 14, 2 | 2016-06-14 |
| 19-nor C3, 3-disubstituted C21-n-pyrazolyl Steroids And Methods Of Use Thereof App 20160108080 - Martinez Botella; Gabriel ; et al. | 2016-04-21 |
| 19-nor Neuroactive Steroids And Methods Of Use Thereof App 20160083418 - Martinez Botella; Gabriel ; et al. | 2016-03-24 |
| 19-nor C3, 3-disubstituted C21-c-bound Heteroaryl Steroids And Methods Of Use Thereof App 20160083417 - Martinez Botella; Gabriel ; et al. | 2016-03-24 |
| 19-nor Neuroactive Steroids And Methods Of Use Thereof App 20160068563 - Martinez Botella; Gabriel ; et al. | 2016-03-10 |
| RORgammaT INHIBITORS App 20150297566 - Karstens; Willem Frederik Johan ; et al. | 2015-10-22 |
| RORgammaT inhibitors Grant 9,095,583 - Karstens , et al. August 4, 2 | 2015-08-04 |
| RORgammaT INHIBITORS App 20140038942 - Karstens; Willem Frederik Johan ; et al. | 2014-02-06 |
| Niacin Receptor Agonists, compositions Containing Such Compounds and Methods of Treatment App 20110028462 - Colletti; Steven L. ; et al. | 2011-02-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 